Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
iCeutica
AddedFeb 15, 2024
UpdatedJun 18, 2026
iCeutica

iCeutica

Pre-Seed

US-based iCeutica develops improved pharmaceutical products, innovates drug delivery methods, and extends product lifecycles.

HQ
Philadelphia, PA, US
Founded
2011
Overview
Compare
Fundraising
Employees

iCeutica, based in Princeton, United States, focuses on developing improved pharmaceutical products and innovative drug delivery methods.

Utilizing their SoluMatrix platform, they enhance generics and late-stage new chemical entities (NCEs) and extend the lifecycle of marketed products with new formulations and delivery methods, securing renewed patent protection and FDA exclusivity.nniCeutica has made significant strides in the pharmaceutical industry by partnering with leading companies to reformulate and improve existing drugs. Their work has led to the successful enhancement of various products, ensuring better efficacy and extended market presence.

iCeutica - Similar Companies

Ikaria logo

Ikaria

PharmaIN logo

PharmaIN

pharmain.com

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Continuus Pharmaceuticals logo

Continuus Pharmaceuticals

InSitu Biologics logo

InSitu Biologics

G2B Pharma logo

G2B Pharma

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Protect Pharmaceutical logo

Protect Pharmaceutical

Icvrx logo

Icvrx

NovaDel Pharma logo

NovaDel Pharma

Catalent logo

Catalent

catalent.com

Iontera logo

Iontera

Trilogic Pharma logo

Trilogic Pharma

trilogicpharma.com

AcousticaBio logo

AcousticaBio

acoustica.bio

Credence MedSystems logo

Credence MedSystems

iCeutica - Quick Facts

Who are iCeutica's competitors?

Companies similar to iCeutica include Ikaria, PharmaIN, Iacta Pharmaceuticals and Continuus Pharmaceuticals.

When was iCeutica founded?

iCeutica was founded in 2011.

Where is iCeutica's headquarters located?

iCeutica's headquarters is located in Philadelphia, PA, US.

When was iCeutica's last funding round?

iCeutica's most recent funding round was for $1M (USD) in March 2011.

How much has iCeutica raised to-date?

As of Mar 21, 2011, iCeutica has raised a total of $5.1M (USD).

How many employees does iCeutica have?

iCeutica has 11 employees as of Feb 4, 2024.

iCeutica - Classification

Ownership
  • Private
Technology
  • Drug Delivery
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 20 more industry codes
NAICS
  • 230000Construction
  • 238000Specialty Trade Contractors
  • 238200Building Equipment Contractors
  • 238220Plumbing, Heating, and Air-Conditioning Contractors
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 1700Construction-special Trade Contractors
  • 1710Plumbing, Heating And Air-conditioning
  • 1711Plumbing, Heating and Air-Conditioning
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified